Additionally, Ray et al. (2011) suggested that CSF p-tau concentration was significantly increased in the NPH patients with disease duration of more than one year and that the ratio of p-tau to Aβ42 may be a useful tool for predicting the possibility of NPH patients to also develop other neurodegenerative disorders including AD [38]. The gene discussed is MAPT; the disease is normal pressure hydrocephalus.